201 related articles for article (PubMed ID: 22286581)
21. New strategies in estrogen receptor-positive breast cancer.
Johnston SR
Clin Cancer Res; 2010 Apr; 16(7):1979-87. PubMed ID: 20332324
[TBL] [Abstract][Full Text] [Related]
22. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
23. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
[TBL] [Abstract][Full Text] [Related]
24. Translating basic research in cancer patient care.
Maugeri-Saccà M; De Maria R
Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
[TBL] [Abstract][Full Text] [Related]
25. Personalized medicine for non-small-cell lung cancer.
Mok TS; Zhou Q; Leung L; Loong HH
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
[TBL] [Abstract][Full Text] [Related]
26. Personalized medicine: marking a new epoch in cancer patient management.
Diamandis M; White NM; Yousef GM
Mol Cancer Res; 2010 Sep; 8(9):1175-87. PubMed ID: 20693306
[TBL] [Abstract][Full Text] [Related]
27. [Biological network modelling and precision medicine in oncology].
Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
[TBL] [Abstract][Full Text] [Related]
28. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract][Full Text] [Related]
29. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
30. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
31. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
32. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathology as the driving force for personalized oncology.
Oktay MH; Hui P
Expert Rev Mol Diagn; 2012 Nov; 12(8):811-3. PubMed ID: 23249199
[TBL] [Abstract][Full Text] [Related]
34. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
35. Personalized treatment of colorectal cancer.
Arnold D; Stein A
Onkologie; 2012; 35 Suppl 1():42-8. PubMed ID: 22286587
[TBL] [Abstract][Full Text] [Related]
36. Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products.
Efferth T
Planta Med; 2010 Aug; 76(11):1143-54. PubMed ID: 20486071
[TBL] [Abstract][Full Text] [Related]
37. Need for a paradigm shift in cancer prevention and clinical oncology.
Ebert MP; Schmid R; Röcken C
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1363-7. PubMed ID: 17944562
[TBL] [Abstract][Full Text] [Related]
38. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
[TBL] [Abstract][Full Text] [Related]
39. Tapping the potential of quantum dots for personalized oncology: current status and future perspectives.
Chen C; Peng J; Sun SR; Peng CW; Li Y; Pang DW
Nanomedicine (Lond); 2012 Mar; 7(3):411-28. PubMed ID: 22385199
[TBL] [Abstract][Full Text] [Related]
40. [Quinze questions importantes à se poser en oncologie en 2015].
Blay JY; Tredan O; Ray-Coquard I; Rivoire M; Mehlen P; Puisieux A; Bachelot T
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S22-6. PubMed ID: 26118872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
